Lantern Pharma Inc. Escrow Deposits Related to Property Sales
Lantern Pharma Inc. (LTRN) reported Escrow Deposits Related to Property Sales of $459.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-03.
Discontinued › Cash Flow
us-gaap:EscrowDepositsRelatedToPropertySales · last filed 2022-05-03
- Lantern Pharma Inc. escrow deposits related to property sales for the quarter ending 2022-03-31 was $459.00K.
| Period end | Escrow Deposits Related to Property Sales 3 month |
|---|---|
| 2022-03-31 | $459.00K 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |